OMRON uses cookies to improve your experience on this website. By continuing to use the website, you hereby agree to our Privacy and Cookie Policy X

  • Corporate
  • Asia Pacific

OMRON Healthcare to Set Up Its First Manufacturing Factory in India

June 07, 2023

OMRON Healthcare to Set Up Its First Manufacturing Factory in India

OMRON Healthcare Co., Ltd. has announced a plan to establish a manufacturing factory at ORIGINS by Mahindra, Chennai (*1), in the Indian state of Tamil Nadu.

A memorandum on the establishment of the factory was signed in the presence of the prime dignitary of state, Mr. M.K. Stalin, Chief Minister of the Tamil Nadu State Government, and the factory is expected to begin manufacturing Blood Pressure Monitors from March 2025 onward.

India’s GDP annual growth rate is expected to be around 6% until 2030 and the population is expected to reach 1.66 billion in 2050 (*2). With the growth in economy and population, one can also notice a rise in the number of lifestyle disease patients. Among these types of diseases, hypertension is one of the most common causes of cerebro-cardiovascular diseases such as stroke and heart failure. Even though the promising population of India juggles such health issues daily, the penetration rate of blood pressure monitors remains low at around 2% (*3). The establishment of the manufacturing factory and the steady distribution structure is OMRON’s efforts to deliver blood pressure monitors to as many people as possible in India. Thereby fulfilling its vision of "Going for ZERO" (achieving zero cerebro-cardiovascular events). 

More details about the factory:
Date of establishment: July 14, 2022
Operation start date: March 2025 (TBD)
Area size: approx. 24,000 m2
Items to be manufactured: Blood pressure monitors

(*1) An industrial cluster and a joint venture between Mahindra World City in Chennai and Sumitomo Corporation of Japan
(*2) UN report
(*3) In-house research

About The Author


Corporate Communications Department - Asia Pacific


Save my name, email, and website in this browser for the next time I comment.